Scientists Discover a Molecular Repulsion System That Keeps Blood Pressure in Check

Every heartbeat pushes blood through a branching network of arteries whose diameter is constantly adjusted by the autonomic nervous system. Among the most important of these adjustments is the sympathetic innervation of peripheral resistance arteries, the fine nerve fibers that wrap around vessel walls and command the smooth muscle inside them to constrict or relax. Despite the fundamental role this wiring plays in blood flow regulation and in the cardiovascular response to stress, biologists have long lacked a clear picture of how the nerves find their way to arteries during development. A new study published in Nature Communications by Emilie Simonnet, Sabrina Martin, Isabelle Brunet and colleagues now reveals that a single axonal guidance molecule, EphrinA4, acts as a molecular boundary keeper that prevents sympathetic nerves from over-colonizing arteries, and that losing this signal drives blood pressure upward in male mice.

The discovery centers on a well-known family of developmental signaling proteins. Ephrins are membrane-bound ligands that bind to receptors of the Eph family, and their interactions are famous for steering growing axons toward or away from particular territories in the embryonic nervous system. In the new work, the researchers show that EphrinA4 is produced by arterial smooth muscle cells, the contractile cells that form the muscular wall of blood vessels. When sympathetic axons carrying the EphA4 receptor approach these vessels, the EphrinA4-EphA4 interaction generates a repulsive signal that holds the nerve fibers at a controlled distance. In other words, the artery itself tells the sympathetic nervous system how much innervation it will tolerate, using the same molecular language that shapes neural circuits elsewhere in the body.

To test what happens when this repulsion is removed, the team engineered a sophisticated genetic tool, the EphA4-flox-TH-cre mouse line. In these animals, the EphA4 receptor can be specifically inactivated in sympathetic neurons, identified by their expression of tyrosine hydroxylase, the rate-limiting enzyme in catecholamine synthesis. This strategy spared EphA4 function in other tissues and focused the deletion on the sympathetic axons themselves. The result was striking: without the receptor that allows them to sense the smooth muscle cell’s repulsive cue, sympathetic fibers invaded peripheral arteries far more extensively than normal, and this hyperinnervation persisted throughout the animals’ lives rather than being corrected during maturation.

The anatomical change had immediate functional consequences. Sympathetic nerve endings release norepinephrine onto vascular smooth muscle, and the density of that innervation determines how strongly the vessel is commanded to constrict. In the mice lacking EphA4 in sympathetic neurons, the researchers measured a significant increase in arterial tone, reflected in elevated resistivity and exaggerated vasoconstriction of the peripheral vasculature. The vessels were, in effect, receiving too much sympathetic drive, squeezing down on the blood flowing through them and increasing the resistance against which the heart must pump.

That increased peripheral resistance translated directly into systemic hypertension. At rest, the mice with hyperinnervated arteries showed elevated arterial blood pressure compared with control animals. More dramatically, when the animals were subjected to acute stress, their blood pressure surged to markedly higher levels than in normal mice. This stress amplification is particularly significant because exaggerated blood pressure responses to stress in humans are a recognized risk factor for the later development of sustained hypertension and cardiovascular disease. The mouse model thus reproduces a clinically relevant pattern: a vascular wiring defect that may remain silent at rest but becomes dangerous when the sympathetic system is activated.

The sex specificity of the finding is an important caveat and a scientific puzzle in its own right. The elevated blood pressure phenotype was observed in male mice, and the authors are careful to frame their conclusions accordingly. Sex differences in sympathetic control of the circulation are well documented, with estrogens and other factors modulating vascular tone and autonomic reflexes differently in females. Whether the EphrinA4-EphA4 pathway behaves differently in female animals, or whether compensatory mechanisms mask the effect, remains an open question that the study does not resolve but clearly raises for future work.

Technically, the study stands out for the way it links a developmental mechanism to adult physiology. By deleting the receptor in sympathetic neurons rather than in the vessel wall, the investigators could attribute the hyperinnervation to a loss of axonal repulsion rather than to a primary defect in smooth muscle cells. The lifelong persistence of the excess innervation indicates that the EphrinA4-EphA4 checkpoint operates during the establishment of arterial innervation and that the mature nervous system does not prune the surplus connections later. Blood pressure was assessed under both basal conditions and during acute stress challenges, allowing the team to separate resting sympathetic tone from the dynamic reactivity of the system, and the concordant findings across these measures strengthen the causal chain from molecule to wiring to physiology.

The broader significance of the work lies in reframing hypertension as a disease that can originate in developmental wiring errors, not only in kidney dysfunction, hormonal imbalance, or dietary factors. A substantial fraction of human hypertension is classified as essential, meaning its root cause is unknown, and autonomic overactivity has long been suspected to contribute. If an analogous repulsive mechanism sculpts sympathetic innervation of human resistance arteries, then genetic or environmental interference with Ephrin signaling could predispose some individuals to an overwired vasculature and, consequently, to elevated blood pressure under stress. The finding also connects vascular biology to neurobiology in a way that few previous studies have: the artery is not a passive target of innervation but an active participant that uses guidance cues to set its own sympathetic input.

Therapeutic implications, while speculative at this stage, are tantalizing. Current antihypertensive drugs include beta-blockers, which blunt the cardiac effects of sympathetic signaling, and alpha-blockers, which relax vascular smooth muscle, but none of them corrects the underlying wiring. A pathway that negatively regulates arterial innervation suggests the possibility, however distant, of interventions that modulate EphrinA4 or EphA4 signaling to normalize vascular sympathetic supply. Any such approach would face formidable challenges, since Eph receptors and ephrins participate in angiogenesis, tissue repair, and cancer biology, and the male-specific nature of the phenotype complicates extrapolation to patients of both sexes. Still, the study provides a proof of principle that vascular innervation density is a tunable parameter with direct consequences for blood pressure.

For now, the most immediate value of the research is conceptual. It identifies EphrinA4 in arterial smooth muscle cells as a repulsive ligand that restrains sympathetic arterial innervation via the EphA4 receptor on sympathetic axons, and it demonstrates in male mice that releasing this brake increases arterial tone, resting blood pressure, and the pressor response to acute stress. The work emerged from a broad French collaboration spanning the Center for Interdisciplinary Research in Biology at the Collège de France, the Paris Centre de Recherche Cardiovasculaire, and teams in Angers, Nantes, Rouen, Montpellier, and Paris, and it was supported by Inserm, the Agence Nationale de la Recherche, and the Fondation pour la Recherche Médicale. As the authors and their colleagues continue to dissect this pathway, the idea that a blood pressure problem can begin with a misdirected nerve fiber is likely to reshape how researchers think about the origins of hypertension, and it offers a vivid reminder that the circuits guiding our nerves are written into the very walls of our arteries.

Subject of Research: The role of EphrinA4/EphA4 axonal guidance signaling in arterial sympathetic innervation and blood pressure regulation in mice

Article Title: EphrinA4/EphA4 controls blood pressure via arterial sympathetic innervation in male mice

Article References: EphrinA4/EphA4 controls blood pressure via arterial sympathetic innervation in male mice. (n.d.). https://doi.org/10.1038/s41467-026-78388-x

Image Credits: AI Generated

DOI: 10.1038/s41467-026-78388-x

Keywords: EphrinA4, EphA4, sympathetic innervation, blood pressure, hypertension, vascular smooth muscle, axonal guidance, arterial tone, autonomic nervous system, norepinephrine, neurovascular interactions, mouse models